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AbstrACt
Objectives Employment following illness is associated 
with better physical and psychological functioning. This 
study aimed to assess the feasibility and acceptability 
of a theoretically led workbook intervention designed to 
support patients with cancer returning to work.
Design Parallel-group randomised controlled trial with 
embedded qualitative interviews.
setting Oncology clinics within four English National 
Health Service Trusts.
Participants Patients who had received a diagnosis of 
breast, gynaecological, prostate or colorectal cancer and 
who had been receiving treatment for a minimum of two 
weeks.
Intervention A self-guided WorkPlan workbook designed 
to support patients with cancer to return to work with 
fortnightly telephone support calls to discuss progress. The 
control group received treatment as usual and was offered 
the workbook at the end of their 12-month follow-up.
Outcome measures We assessed aspects of feasibility 
including eligibility, recruitment, data collection, attrition, 
feasibility of the methodology, acceptability of the 
intervention and potential to calculate cost-effectiveness.
results The recruitment rate of eligible patients was 
44%; 68 participants consented and 58 (85%) completed 
baseline measures. Randomisation procedures were 
acceptable, data collection methods (including cost-
effectiveness data) were feasible and the intervention was 
acceptable to participants. Retention rates at 6-month and 
12-month follow-up were 72% and 69%, respectively. 
At 6-month follow-up, 30% of the usual care group had 
returned to full-time or part-time work (including phased 
return to work) compared with 43% of the intervention 
group. At 12 months, the percentages were 47% (usual 
care) and 68% (intervention).
Conclusions The findings confirm the feasibility of a 
definitive trial, although further consideration needs to be 
given to increasing the participation rates among men and 
black and ethnic minority patients diagnosed with cancer.
trial registration number ISRCTN56342476; Pre-results.
IntrODuCtIOn 
Almost half of adult cancer survivors are of 
working age,1 yet patients with cancer are 
1.4 times more likely to be unemployed than 
healthy individuals.2 Patients with cancer 
may experience ongoing negative outcomes 
from the disease or treatment (including 
pain, fatigue and low mood) that can impact 
everyday functioning, including work.3 4 
Return to work rates vary across cancer types5; 
however, longer return to work times are asso-
ciated with certain treatments (eg, chemo-
therapy6), fatigue7 or a non-supportive work 
environment.8 Predictors of return to work 
include optimal symptom management (as 
over a quarter of cancer survivors report high 
symptom burden 1 year postdiagnosis, even 
after the end of treatment9), implementing 
appropriate workplace adaptations, as well as 
specific cancer (ie, beliefs about the conse-
quences of cancer) and treatment-related 
perceptions (ie, beliefs about controlling the 
effects of cancer at work).
Employment is important not only for 
individual financial and societal economic 
strengths and limitations of this study
 ► The study assessed the feasibility and acceptabili-
ty of a randomised controlled trial (RCT) of a theo-
ry-led intervention to support return to work among 
patients with a diagnosis of breast, gynaecological, 
colorectal or prostate cancer.
 ► The intervention used a workbook format compris-
ing paper-based exercises and the development of a 
return to work plan.
 ► A mixed method design, with nested qualitative in-
terviews, was used to assess the acceptability of 
the intervention and the feasibility of the RCT and to 
determine the utility of the patient-reported outcome 
measures.
 ► Only four cancer types were included that may limit 
generalisability.
 ► Views of male participants, as well as black and 
ethnic minority participants, were under-represent-
ed, as the majority of participants were female and 
Caucasian, and all were English speaking.
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reasons10 but because being out of work is thought to 
contribute to, and aggravate, adverse health outcomes.1 11 
Returning to and staying in work following illness is asso-
ciated with better physical and psychological functioning. 
Not working is associated with reduced self-esteem, 
lowered self-efficacy and decreased belief in one’s ability 
to return to the workplace.12 Furthermore, work is an 
important component of quality of life,13 and impaired 
work is associated with increased depression and anxiety 
among patients with cancer.14
Several interventions to support working have been 
developed across illness groups, including musculoskel-
etal disorders, back pain and multiple sclerosis. These 
interventions have tended to focus on ergonomic adap-
tation within the workplace with the aim of minimising 
the risk of physical injuries, likely to be experienced by 
these patient groups. Interventions targeted at patients 
with cancer include a 12-week occupational physician-led 
intervention focused on increasing physical activity to 
support return to work15; a case management approach 
involving signposting/referring patients to services (eg, 
physiotherapy, occupational or psychological therapy) to 
support return to work16; and a tool that cancer survivors 
use to guide discussions about working.17 However, this 
tool focused on interactions with employers and health-
care professionals and not on patients’ beliefs and barriers 
that impact workability (one’s perception of one’s ability 
to work) and influence work behaviour. Furthermore, a 
Cochrane review reported low quality evidence for return 
to work rates for psychoeducational interventions (inter-
ventions that encompass a broad range of activities that 
combine educational and other activities such as coun-
selling and supportive care); however, this was based 
on only two studies: one that focused on teaching self-
care behaviours to manage fatigue and one comprising 
lectures focused on side effects, stress and coping. The 
review concluded that there was a need for more high-
quality randomised controlled trials (RCTs).18 Further-
more, a meta-synthesis of qualitative research studies 
highlighted the need for vocational interventions with 
patients with cancer to be person-centred and for such 
interventions to acknowledge the role of social, clinical 
and work-related factors.19
The WorkPlan intervention is theoretically led and 
uses the self-regulation model20 and goal-setting theory.21 
WorkPlan was developed following the Medical Research 
Council (MRC) guidelines for the development of 
complex interventions22 and used an intervention 
mapping methodology for designing and implementing 
complex interventions or programmes. WorkPlan differs 
from other published interventions in that it supports 
people diagnosed with cancer to prepare for returning to 
work by creating a space to envisage and construct a future 
at work, then supporting patients to develop appropriate 
communication and planning skills to support returning 
to work. The workbook comprises activities aimed at elic-
iting beliefs about the impact of cancer and of the person’s 
perceived workability, identifying actions to facilitate the 
process of returning to work and to support specific tasks 
once within the workplace. The individual then outlines 
concrete steps to achieve their goals through a structured 
return to work plan.
AIms
The primary objective of the study was to trial the Work-
Plan intervention and data collection materials to deter-
mine if the materials were acceptable to participants and 
whether participants were able to provide full answers. 
The aims were to:
1. Identify whether the materials and intervention were 
acceptable and understandable.
2. Determine whether the recruitment target was achiev-
able and identify the most successful methods of re-
cruitment.
3. Determine the acceptability of the randomisation pro-
cess.
4. Identify retention rates in both arms.
5. Determine if data were obtainable to enable a full 
cost-effectiveness analysis in a definitive trial.
methODs
A full description of the protocol is available elsewhere.23
Participants
The target was to recruit 60 participants (30 randomised 
into each group). This was not a hypothesis testing trial, 
and the sample size was based on pragmatic assumptions 
around feasible recruitment figures and the number 
of participants required to estimate the key parameters 
around the feasibility of a full RCT.
Inclusion criteria
Inclusion criteria include: (A) received a diagnosis breast, 
gynaecological, prostate or colorectal cancer; (B) had not 
been classified as having metastatic disease or recurrence; 
(C) at least 2 weeks post-treatment initiation; (D) aged 
18–70 years; (E) working at the time of diagnosis; and (F) 
and not working at time of recruitment but intended to 
return to work.
recruitment and randomisation
Participants were recruited by researchers and research 
nurses through four English National Health Service 
Trusts UK. Participants were identified through cancer 
clinics and multidisciplinary team meetings and by 
placing posters and leaflets in clinics, support and 
information services, chemotherapy suites and CT scan 
waiting areas. All recruitment sites were based in tertiary 
care centres. In addition, collaborating clinicians were 
provided with leaflets and information packs outlining 
the study. We translated recruitment materials into the 
five most commonly spoken languages among people 
of working age in Birmingham (2011 Census): Bengali, 
Chinese (standard), Polish, Punjabi and Urdu. Funding 
was available to provide interpreters if required, and 
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we were able to translate the workbook into different 
languages if required by participants. Potential partici-
pants who expressed interest in the study were provided 
with a study information sheet and asked to provide their 
contact details for the researcher to phone and confirm if 
they were interested in participating. Eligible participants 
who expressed an interest in participation were screened 
over the phone and were sent an invitation for an assess-
ment interview (which included an explanation of the 
randomisation process) at the hospital or over the tele-
phone. All participants were required to provide written 
consent to participate.
Following the assessment interview the researchers used 
an online and text-based randomisation system (Sealed 
Envelope Ltd) to randomise participants at a ratio of 1:1 
between the intervention group and usual care group. 
Participants were stratified by age (18–50 years or 51 
years and over) and cancer type (breast, bowel, gynaeco-
logical or urological). Participants who consented into 
the study were logged according to recruitment site using 
the National Institute for Health Research’s Central Port-
folio Management System.
Intervention
The WorkPlan package is a 4-week guided workbook inter-
vention consisting of structured sections and activities 
to provide guidance and support to patients. The work-
book is broken down into chapters. Chapter one focused 
on thinking about illness and treatment (based around 
the illness perceptions component of the Self-Regula-
tion Model) and includes causes of cancer, symptoms, 
beliefs about efficacy of treatment and consequences of 
living as a survivor of cancer. It then explores the partic-
ipant’s beliefs about the impact of cancer and treatment 
on their ability to function in the workplace, including 
suggestions for management. The chapter concludes by 
examining participants’ emotional reactions to treatment 
and support/strategies to manage these. Chapter two is 
focused on setting and achieving goals (based on Goal 
Theory) including the goal-setting process, identifying 
and overcoming barriers and using support. Chapter 
three works on building confidence, including ways 
to boost confidence. This chapter concludes by exam-
ining fatigue and ways to to identify and manage fatigue 
triggers. Chapter four focuses on developing an action 
plan for returning to work and outlines how to initiate 
discussions and deal with difficult questions within the 
workplace.
Participants were encouraged to work through chap-
ters in turn during each week of the intervention period, 
allocating around 120 min per week. However, this was 
not strictly monitored, and participants had the oppor-
tunity to work through the intervention at a pace that 
suited them and their timeframe for returning to work. 
Participants incorporated all elements from the work-
book into a personal return to work plan, which they were 
encouraged to develop in the final week. A resources 
section signposted participants towards relevant avenues 
of further support. Multiple copies of the return to work 
planning page were available to encourage changes to be 
made when necessary, and these plans were used as a tool 
when meeting with employers to aid discussion around 
returning to work. Service users in the original pilot work 
(of the materials and study design) were concerned about 
raising work-related issues too early with their employer 
and stated that they would prefer to engage with their 
workplace after completing the intervention, when they 
felt better able to represent their view and had formed 
a return to work plan. Therefore, the intervention does 
not have a specific employer component, but rather the 
workbook promotes skills to enable communication with 
employers.
Control group
Participants received usual care, which focused on clin-
ical care and optimal symptom management. In order to 
prevent participants from undertaking activities in the 
workbook, the information sheets and prerandomisation 
discussion did not include the content or focus of the 
intervention, and participants were not offered the work-
book until after their 12-month follow-up.
Participants in both groups were able to access other 
information and support relating to work and were there-
fore asked to record any resources or information they 
used during the trial.
study outcomes
Primary outcome
The primary outcomes were time to return to work and 
return to work rates at 6-month and 12-month follow-ups. 
Any changes in working status, for example, contracted 
hours and duties, were documented along with specific 
reasons for non-return to work (eg, unavailability of 
job and ongoing medical concerns) to determine 
whether to incorporate specific reasons for non-return as 
measures in a full trial.
Secondary outcomes
Secondary outcome measures included mood, satisfac-
tion with return to work and satisfaction with the return 
to work process.
Data were collected at four time points: baseline (T0), 
4-week postintervention (intervention group) or 4-week 
postrandomisation (usual care group) (T1) and 6-month 
postrandomisation (T2) and 12-month postrandomi-
sation (T3) follow-ups. At each time point, participants 
were mailed a questionnaire pack (with a prepaid self-ad-
dressed envelope) that comprised: (1) Illness Perceptions 
Questionnaire-Revised24; (2) Brief Illness Perception 
at Work Scale25; (3) Hospital Anxiety and Depression 
Scale26; (4) Work Ability Index27; (5) satisfaction with 
return to work if returned to work (single item); (6) 
Satisfaction with Work Scale28 (if returned to work); (7) 
EuroQoL-5D-5L (EQ-5D-5L) (quality of life)29; (8) visual 
analogue scale measure of quality of life (single item).30
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Work status and healthcare utilisation
Participants provided details of their use of services and 
employment activity via text message (using JANET; 
http://www. pageone. co. uk/ services/ janet- txt). A 
maximum of four text messages were sent to participants 
at the end of each month to gather information on their 
work status (ie, full-time, part-time, phased return, sick 
leave and not working), number of days worked that 
month and healthcare utilisation (number of general 
practitioner appointments that month). Monthly inter-
vals were chosen as memory of general practitioner 
appointments is around 4 weeks, so we could not rely on 
accurate recall of healthcare utilisation at 6-month ques-
tionnaire follow-ups.31 32
Adverse events
A record sheet was produced for the recording of adverse 
events and provided as part of the study file to all partici-
pating sites. If participants reported any negative events, 
including low mood or anxiety, as a result of taking part 
in the study or undertaking the intervention, or if partic-
ipants withdrew from the study due to an adverse event, 
then these were recorded on the record sheet.
Qualitative interviews
The aim of the postintervention and 12-month follow-up 
interviews was to better understand the effects of the inter-
vention and to explore how the intervention was expe-
rienced by participants. Participants were approached 
sequentially until the recruitment target was reached. 
Interviews were conducted over the telephone or face 
to face, depending on the participant’s preference. The 
postrandomisation interview focused on: (1) beliefs 
about work and cancer; (2) experience of employment 
and work values; (3) ways in which returning to work 
could be supported; and (4) expectations of the Work-
Plan intervention. Twelve-month interviews explored: (1) 
beliefs about cancer and work and how these were chal-
lenged over the preceding year, (2) general perceptions 
of the trial and (3) the personal return to work process of 
each individual.
Data analysis
Descriptive statistics for all between group outcome 
measures are presented, including means (SD) and 
frequencies. The purpose of this feasibility study was not 
hypothesis testing, and the sample size was underpowered 
to undertake the full analysis that would be used in a full 
trial (analysis of covariance adjusting for baseline values).
Economic analysis
Although an economic evaluation was not suitable in 
the context of a feasibility trial, we did aim to determine 
whether data would be obtainable to enable a full cost-ef-
fectiveness analysis in a definitive trial.
Qualitative data
Interviews were audio-recorded, transcribed verbatim 
and analysed using the framework method33 to 
identify emergent themes. The Consolidated Criteria for 
Reporting Qualitative Research was used to guide the 
presentation of the qualitative analyses. Findings from 
the quantitative and qualitative analyses are presented 
concurrently, although fuller details of the methodology 
for the interviews and of the qualitative findings have 
been reported elsewhere.34
Patient and public involvement
The WorkPlan intervention was developed following a 
prospective study, which followed patients with cancer for 
1 year following the end of treatment to identify factors 
that influenced the likelihood of not returning to work. 
The WorkPlan intervention was then refined with input 
from 15 cancer survivors who provided feedback on the 
content and wording of the workbook and format of 
delivery (workbook or face-to-face sessions). One steering 
group member and author (PR) was a patient representa-
tive and provided input on recruitment, study design and 
materials. Study participants were asked if they would like 
a lay summary of the study findings at the end of the study, 
and this was sent to all who indicated that they would.
results
eligibility and recruitment
During the recruitment period, 324 patients were identi-
fied and assessed for eligibility and 170 participants were 
ineligible (reasons included not working at time of diag-
nosis, older than 70 years or already returned to work). A 
further 154 patients were considered eligible (figure 1). 
Eighty-six of these participants declined to participate 
resulting in 68 participants (44%) being consented and 
randomised into the study. Although 68 participants 
consented to take part in the study, only 58 returned 
Figure 1 Flow of participants through the study (showing 
cumulative attrition at each time point from point of 
randomisation).  
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fully completed T0 (baseline) questionnaires. There was 
no difference between those who returned the question-
naires and those who did not on any of the demographic 
or clinical measures, site of recruitment, size of employer 
or randomised group. In the interviews participants 
reported that the randomisation process was acceptable.
Furthermore, 23 participants in the intervention group 
were interviewed at the postintervention (T1) time point, 
which exceeded our target of 20. At the 12-month (T3) 
follow-up, 22 participants from the intervention group 
and 20 from the control group participated in an inter-
view, which exceeded our target of 40 participants in total.
sample characteristics
We were unable to collect demographic information of 
participants who chose not to consent into the study. 
The majority of participants self-identified as being 
white (88%), followed by African/Afro-Caribbean (7%) 
and Asian (5%) (table 1). There was significantly more 
women (79%) than men (21%) recruited into the study. 
This reflected the large percentage of the participants 
who had been diagnosed with breast cancer (50%) and 
gynaecological cancers (15%) compared with prostate 
(16%) and colorectal (19%) cancers. The majority of 
Table 1 Participant demographics
Usual care (n=30) Intervention (n=38) All (n=68)
Age, mean (range) 51.2 (35–63) 50.4 (25–65) 50.8 (25–65)
Gender, n (%) 
  Female 26 (87) 28 (74) 54 (79) 
  Male 4 (13) 10 (26) 14 (21)
Marital status, n (%) 
  Married or living with partner 20 (67) 28 (74) 48 (71) 
  Divorced or separated 6 (20) 6 (16) 12 (18) 
  Single and never married 4 (13) 4 (10) 8 (11)
Dependent children living at home, n (%) 13 (43) 13 (34) 26 (38)
Ethnicity, n (%) 
  White 25 (83) 35 (90) 60 (88) 
  Asian 2 (8.5) 1 (3) 3 (5)
  African/Afro-Caribbean 
Highest education level, n (%) 2 (8.5) 3 (7) 5 (7) 
  Did not complete secondary education 0 (0) 1 (3) 1 (1) 
  Secondary education (to 16  years) 14 (47) 9 (24) 23 (34) 
  Further education (to 18  years) 3 (10) 7 (18) 10 (15) 
  Higher education (degree or higher) 13 (43) 21 (55) 34 (50)
Cancer diagnosis, n (%) 
  Breast 16 (53) 18 (46) 34 (50) 
  Urological 2 (7) 9 (24) 11 (16) 
  Bowel 7 (23) 6 (16) 13 (19) 
  Gynaecological 5 (17) 5 (14) 10 (15)
  Comorbidities, n (%) 
  1 8 (27) 8 (21) 16 (24) 
  2 1 (3) 0 (0) 1 (1) 
  3 or more 6 (20) 5 (13) 11 (16)
Flexible working allowed, n (%) 7 (23) 18 (48) 25 (37)
Number of months entitled to full sick pay, 
mean (SD)
3.9 (2.7) 4.8 (3.2) 4.4 (2.9)
Work status at 6-month follow-up, n (%) 
  Working full/part time* 9 (30) 16 (43) 25 (37)
Work status at 12 -month follow-up, n (%) 
  Working full/part time* 14 (47) 26 (68) 40 (59)
*Including phased return to work.
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participants were married or living with a partner (71%), 
and half were educated to degree level of above (50%). 
Comorbidities (defined as any concurrent diagnosis of a 
physical or psychological disorder for which participants 
were currently receiving treatment) were more common 
among the usual care (50% reporting one or more 
comorbidities) than the intervention group (29%), and 
this could be explored in a future trial as a possible medi-
ator of returning to work.
Data collection
Attrition
Attrition rates (determined by non-return of the ques-
tionnaire at that time point) from point of randomisa-
tion to 1 month (T1), 6 months (T2) and 12 months (T3) 
follow-up were 24.5% (29% in intervention and 20% in 
control group), 28% (29% in intervention and 27% in 
control group) and 31%, respectively (32% in interven-
tion and 30% in control group). This was slightly higher 
than the conservative 25% estimate we had forecast at 
12 months. Attrition was higher when participants were 
recruited into the trial by research nurses (37% at T3) 
rather than the study research assistants (19% at T3), 
potentially indicating that participants are more likely to 
remain in a study when they had developed a relationship 
(through the information and consent process) with a 
researcher on the project.
Acceptability of the outcome measures and data collection 
methods
For the most part, the outcome measures were accept-
able, and no participants raised study burden as a concern 
during the interviews. Participants who returned the 
questionnaires at each time point mostly returned fully 
completed questionnaires and did not systematically leave 
questions unanswered. We trialled using a text-based data 
collection system for collecting monthly work data and 
general practitioner (GP) visits. This was acceptable to 
the majority of participants; only two participants did not 
have access to a mobile phone and so we used monthly 
emails to collect these data with these participants.
Adverse events
No adverse events were reported during the feasibility 
trial.
Participants views of the intervention
From the interviews, it was apparent that overall partic-
ipants enjoyed taking part in the intervention and that 
it provided a focus and clarity regarding the process of 
returning to work and options that they might consider. 
The workbook was described as a useful tool that facili-
tated the planning process for returning to work and that 
the exercises within the workbook ‘broke it [the process] 
down into small bits’. It allowed participants to imagine 
the potential problems around roles, tasks and events 
that could arise and plan how to deal with these. Further-
more, by considering interactions in the workplace, such 
as coping with coworkers’ reactions, they were able to 
engage in mental role play to rehearse how to respond, 
gaining confidence in managing a successful return to 
work.
The workbook format of the intervention was well 
received by participants and preferred by the majority of 
participants to the idea of using an online or app version. 
The booklet was seen as convenient (easy to access 
compared with an online version), simple to transport 
and could easily be shared with others.
I think the benefit of doing the booklet with a pen in 
your hand is that you actually feel more engaged with 
it. You’re writing it and you’re physically owning your 
words. Whereas on the computer I think it would be 
a lot more impersonal. (P24, aged 54 years)
I’ve been able to go to bed and I’ve been able to 
read it. With my phone it’s small, do you know what 
I mean? Things could be missed. If it’s a book where 
you come back to it now and again. It’s there at the 
side of my bed and kind of prompts you to do it. (P10, 
aged 44 years)
However, a minority of interviewees did suggest that it 
would be more secure (requiring a password) and envi-
ronmentally friendly to have an online version.
Although the intervention was perceived as useful, some 
interviewees did highlight areas that could either have 
been more detailed in the booklet or that had not been 
included. The main area where participants required 
greater detail was about managing finances during sick 
leave periods and about financial support that could be 
available to them. This is an area of the current interven-
tion that would need to be adapted before moving to a 
full trial. Furthermore, during the interviews, one partic-
ipant commented on the wording of the booklet, which 
referred to patients having completed treatment, whereas 
the patient was still going through treatment, and this 
made it difficult for them to engage suggesting that the 
booklet might need rewording.
I was still trying to go through treatment and it was 
talking about the process when it had all finished. I 
was still going through treatment, so I remember be-
ing quite annoyed about that. (P15)
Outcomes measures
The primary outcomes were time to return to work and 
return to work rates at 6-month and 12-month follow-ups. 
There were no significant differences between the usual 
care and intervention group in terms of the number of 
days from leaving work to returning to work (usual care 
mean 308 days (SD 74) compared with intervention 
mean of 333 days (SD 153)). The greater number of days 
observed for the intervention group was likely influenced 
by the fact that within the intervention group (mean 
190 days, SD 145), there were a greater number of days 
(non-significant) between leaving and consenting into 
the study (so this group had already been out of work for 
a longer period of time) compared with the usual care 
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group (mean 158 days, SD 100). Although the interven-
tion group reported a greater number of days worked 
per month at 6-month and 12-month follow-up (table 2), 
these did not reach significance, possibly due to lack of 
power. In addition, at 6-month follow-up, 30% of partic-
ipants in the usual care group had returned to full-time 
or part-time work compared with 43% of the intervention 
group. At 12 months, the percentages were 47% (usual 
care) and 68% (intervention).
Regarding secondary outcome measures, the interven-
tion group reported less anxiety and depression-related 
symptoms, although these did not reach significance and 
would need to be examined as part of a fully powered 
RCT. There was potentially a floor effect with the EQ-5D 
(health status) with few symptoms reported at each time-
point, resulting in low scores across participants with 
limited dispersion of the scores.
DIsCussIOn
This study aimed to assess the feasibility and acceptability 
of an RCT of a workbook intervention to support patients 
with cancer in returning to work. Our results indicate that 
the format of the workbook was well received and that 
Table 2 Outcome measures by assessment time point and group
Study group
T0 baseline, 
mean (SD)
T1 
postintervention, 
mean (SD)
T2 6-month 
follow-up, mean 
(SD)
T3 12-month 
follow-up, mean 
(SD)
Emotion (IPQ-R) Usual care 2.7 (0.6) 2.6 (0.7) 2.4 (0.5) 2.6 (0.6)
Intervention 2.9 (0.6) 2.6 (0.7) 2.6 (0.5) 2.7 (0.7)
Timeline (IPQ-R) Usual care 3.3 (0.1) 3.3 (0.6) 3.1 (0.5) 3.0 (0.5)
Intervention 2.9 (0.1) 3.1 (0.7) 3.1 (0.6) 3.0 (0.8)
Illness coherence (IPQ-R) Usual care 3.3 (0.5) 3.3 (0.6) 3.4 (0.6) 3.5 (0.6)
Intervention 3.1 (0.7) 3.1 (0.7) 3.1 (0.7) 3.2 (0.8)
Illness consequences 
(IPQ-R)
Usual care 3.9 (0.7) 3.9 (0.5) 3.9 (0.3) 3.9 (0.3)
Intervention 3.9 (0.7) 4.0 (0.4) 3.8 (0.4) 3.9 (0.4)
Personal control (IPQ-R) Usual care 3.4 (0.8) 3.4 (0.4) 3.4 (0.4) 3.2 (0.4)
Intervention 3.3 (0.8) 3.3 (0.6) 3.3 (0.4) 3.2 (0.7)
Treatment control (IPQ-R) Usual care 3.5 (0.4) 3.5 (0.4) 3.5 (0.4) 3.4 (0.4)
Intervention 3.5 (0.4) 3.4 (0.4) 3.5 (0.3) 3.5 (0.4)
Brief illness perception at 
work scale
Usual care 3.6 (0.5) 3.7 (0.9) 3.6 (0.9) 3.4 (0.5)
Intervention 4.0 (0.9) 3.6 (0.7) 3.4 (1.1) 3.6 (0.9)
EQ-5D-5L (health status) Usual care 2.1 (0.1) 1.8 (0.6) 1.7 (0.5) 1.6 (0.5)
Intervention 1.7 (0.8) 1.6 (0.5) 1.6 (0.4) 1.5 (0.4)
Visual analogue scale 
measure of quality of life
Usual care 56.2 (18.7) 59.3 (20.7) 71.6 (17.9) 75.0 (19.5)
Intervention 61.6 (19.3) 68.0 (22.6) 73.7 (14.7) 77.8 (17.1)
Anxiety (HADS) Usual care 8.3 (4.3) 7.9 (4.4) 7.2 (4.5) 6.7 (3.4)
Intervention 7.2 (4.3) 7.3 (4.5) 6.3 (3.5) 6.1 (4.2)
Depression (HADS) Usual care 5.8 (3.0) 5.0 (3.8) 4.9 (3.6) 4.5 (4.3)
Intervention 6.1 (4.1) 5.6 (4.2) 4.7 (3.5) 3.9 (3.1)
Work ability index (overall) Usual care 4.3 (0.7) 4.4 (3.1) 6.7 (2.8) 7.6 (2.6)
Intervention 2.7 (0.5) 5.4 (3.7) 6.6 (3.4) 7.8 (3.0)
Work ability index (physical 
demands of role)
Usual care 2.5 (0.3) 2.8 (1.1) 3.2 (1.0) 3.8 (1.0)
Intervention 2.3 (0.5) 3.2 (1.2) 3.3 (1.3) 3.9 (1.2)
Work ability index 
(cognitive demands of role)
Usual care 2.7 (0.2) 2.9 (1.2) 3.1 (1.3) 3.7 (1.2)
Intervention 2.5 (0.2) 3.0 (1.3) 3.2 (1.2) 3.9 (1.2)
Satisfaction with work 
scale
Usual care 3.7 (0.7) 3.5 (0.6) 3.5 (0.7) 3.4 (0.6)
Intervention 3.4 (0.9) 3.3 (1.0) 3.3 (1.1) 3.3 (1.0)
Number of days worked 
that month
Usual care – 3.5 (7.7) 5.7 (8.7) 11.5 (10.1)
Intervention – 3.4 (6.5) 8.9 (9.2) 12.4 (7.9)
EQ-5D-5L, EuroQoL-5D-5L; HADS, Hospital Anxiety and Depression Scale; IPQ-R, Illness Perceptions Questionnaire - Revised.
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the exercises within the workbook were engaging and 
useful in the return to work process. However, it should 
be noted that this may be a consequence of acquiescence 
bias or lack of awareness of the utility of an alternative 
to format used within the trial. An unexpected outcome 
was the degree to which participants valued the process of 
writing within a physical workbook. The workbook aided 
them in organising their thoughts, enabling them to 
plan for the future. Expressive writing, or the formation 
of a written narrative exploring the emotional aspects of 
a personal experience, allows an individual to organise 
own thoughts and emotions into a coherent narrative, 
or summary, that can facilitate more effective coping.35 36 
Using the WorkPlan workbook was not intended to act 
as an expressive writing task; however, it enabled partici-
pants to explore thoughts and emotions related to their 
cancer and to work and the work environment including 
organisational (support and shift patterns) aspects of 
their work, a process that participants identified as both 
supportive and enjoyable. There is a clear need for an 
intervention, such as WorkPlan, to support patients in 
planning their return to work and to support them in 
thinking about how they could overcome potential issues 
associated with work tasks, their role (responsibilities) as 
well accommodating ongoing medical care and treatment 
(ie, fitting work requirements around medical consulta-
tions and treatment).
The recruitment rate was 44%, which was acceptable 
and in-line with other studies. However, there were fewer 
men recruited (21%) than we had expected, which was 
due in part to the cancer types that we recruited into the 
study with two-thirds of participants having been diag-
nosed with breast or gynaecological cancers. In a future 
trial, we would widen the range of cancer types that 
would be eligible for inclusion and stratify by gender as 
well as age. The majority of participants also identified as 
being white (88%); however, within the Birmingham area 
(where the majority of recruitment took place), around 
81% of the population were classified as white,37 and there-
fore the findings may not be representative of patients 
with cancer returning to work after treatment. A future 
trial will need to make male and minority recruitment a 
priority and recruitment materials may need amending to 
be more relevant to these groups.38 In addition, although 
we translated recruitment materials into five languages 
to support recruitment of non-English speakers into the 
study, we were unsuccessful in recruiting any non-English 
speakers. However, the main barrier to recruiting non-En-
glish speakers was not necessarily a language barrier but 
rather that that the majority of those approached were 
not working at the time of diagnosis. Finally, half of study 
participants were educated to degree level and, although 
this is in-line with numbers of school leavers entering 
tertiary education in the UK today, it is higher than would 
have been observed among the age groups included in 
this study, and therefore further work is needed to under-
stand the reason for low uptake into the study of people 
leaving education at an earlier age.
Overall, the study design, using a nested qualitative 
evaluation, was found to be feasible. A key strength of this 
study was the mixed methods approach, which allowed 
for triangulation of experiences of the participants. Qual-
itative methods provided depth of understanding and the 
findings, particularly exploration of trial acceptability, 
suggested that participants were generally satisfied with 
the process and found the experience acceptable and 
informative. However, patients may have been inclined 
to produce socially desirable responses, although with 
attrition rates within tolerable limits, there is additional 
support for the acceptability of the study process. Finally, 
the insights emerging from this study relied on in-depth 
qualitative investigation; however, it should be noted that 
the findings are limited to predominately female Cauca-
sian participants.
This was a feasibility study and so efficacy testing was 
not an aim of the study, and the small sample size was 
likely insufficient to detect subtle differences between 
groups. The primary outcome measures were return to 
work rates at 6-month and 12-month follow-ups, and in a 
future trial, we would also use the text-based data collec-
tion system to collect information about actual return to 
work date. Determining the economic cost of the inter-
vention is important given that although there is strong 
evidence of return to work interventions providing cost 
savings from a societal perspective, there is a need to 
ensure that actual intervention costs would be manage-
able once the intervention was implemented.39 The 
outcomes for use in an economic analysis in a full trial 
were found to be feasible and acceptable. In particular, 
the tool for collecting data on work behaviour and GP 
attendance was successful, and the burden on partici-
pants did not appear to be excessive. In a future trial, we 
would also collect information about additional services 
that were used (eg, out of hours primary care services, 
minor injury units and counselling services), the number 
of hours/days of work that are missed (in this trial, we 
collected data on the number of days worked), as these 
could contribute to societal costs. Furthermore, the aim 
of the study was to explore the feasibility of undertaking 
an RCT of the WorkPlan intervention and this, along with 
the small sample size, meant that we did not examine the 
role of socioeconomic factors or type of employment as 
a mediator of returning to work in each of the groups. 
However, these data (including job title and postcode) 
were collected and could be used in a future trial.
Following on from the findings of the feasibility study, 
there are a number of adaptations proposed for a future 
study. A limitation of the current study is that the views of 
black and ethnic minority groups are under-represented. 
The recruitment materials and how patients are identi-
fied and approached will need refining to increase the 
number of men and black and ethnic minority partici-
pants. Attrition was higher among participants recruited 
from sites with research nurses rather than sites where 
the study research assistants recruited, which may be 
partly due to rapport and knowledge of the project, both 
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of which have been reported to impact recruitment.40 
To improve retention, particularly from sites where the 
participants are not recruited by the study research assis-
tants, there needs to be greater effort to build rapport 
with participants and encourage retention in the trial. 
In addition, although we used incentives to encourage 
participation (including a £20 voucher for completing 
the assessment interview), it may be that greater consid-
eration needs to be given to compensating participants 
for their time throughout the 12-month study. A further 
limitation is that the study did not include the views and 
experiences of employers, who may hold negative beliefs 
about the ability of cancer survivors to return to work25 
and therefore impact on the process of returning to work. 
Finally, although we examined engagement and accept-
ability of the intervention (through the interviews), we 
did not test the fidelity of the intervention as part of this 
feasibility trial. Therefore, in a full RCT, we would system-
atically assess intervention fidelity and, where possible, 
incorporate fidelity data in the analysis of outcomes.41
COnClusIOn
This study investigated the feasibility of undertaking an 
RCT of a workbook-based intervention to support patients 
with cancer patients in returning to the workplace. The 
initial results are encouraging and suggest that the inter-
vention was both well received and conveyed benefit to 
participants in supporting return to work after cancer 
treatment. The findings suggest that, with minor modifi-
cations, an effectiveness RCT is warranted.
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